about
The genetics and neuropathology of frontotemporal lobar degenerationNull mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21Progressive dysarthria. Case reports and a review of the literature.Neurophysiological investigation of phonological input: aging effects and development of normative data.Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degenerationImaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings.Posterior cortical atrophy. Two case reports and a review of the literature.TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohortA pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.Cognitive differences between patients with left-sided and right-sided Parkinson's disease. A review.fMRI of developmental stuttering: a pilot study.Quantitative analysis of language production in Parkinson's disease using a cued sentence generation task.Multisubject learning for common spatial patterns in motor-imagery BCI.CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro.Heterogeneity of cognitive dysfunction in Parkinson's disease: a cohort study.Mutations in SACS cause atypical and late-onset forms of ARSACS.Masticatory myorhythmia following pontine hemorrhage.Case-control study of environmental risk factors for Parkinson's disease in Belgium.Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease.Sleep attacks in Parkinson's disease induced by Entacapone, a COMT-inhibitor.Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study.Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.Impaired intentional content learning but spared incidental retention of contextual information in non-demented patients with Parkinson's disease.Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.On the role of cost-sensitive learning in multi-class brain-computer interfaces.Sequential changes in motor speech across a levodopa cycle in advanced Parkinson's disease.Cognate Effects and Executive Control in a Patient With Differential Bilingual Aphasia.Progressive myoclonic epilepsy as an adult-onset manifestation of Leigh syndrome due to m.14487T>C.Three cases of substitution errors leading to hyoscine hydrobromide overdose.Neuromodulatory procedures for gait disorders in Parkinson's disease.Regional cerebral blood flow and episodic memory in Parkinson's disease: a single photon emission tomography study.Quality of life in patients with PD and their caregiving spouses: A view from both sides.Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson's disease.Saccadic ping pong gaze in coma.The pharmacokinetics of [11C]methoxy-norchloroprogabidic acid, a potential PET tracer for GABA receptors in the brain.Cobalt-55 positron emission tomography in recurrent ischaemic stroke.Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study.
P50
Q24615201-B71CF2C7-8678-4277-BDC9-964EFE5E675CQ28253639-5748D03A-D47C-432C-AA29-7BE9D6895AD7Q30577230-5EA75395-22CD-4BC8-8795-E73F0CF310E3Q30609585-A0CE856A-010D-47B3-A226-5FA1FBCECB3BQ33742432-0B6CC091-DEE4-4A8E-8FF9-7015A55318C4Q34038343-F978F677-C7D5-4559-8396-2B69D2818507Q34192772-B19783EE-3CC2-4E2F-AFC1-B11FD383CAEBQ34343023-F4183A73-CA31-40D8-B145-BF01DBA62108Q34605483-17CA4008-EB23-4300-A09E-96DC9F2408CAQ36801066-86FE30A7-F6D4-4D2D-94C7-454E1B1BB2B1Q36801066-FABB759C-93C3-44E3-9E18-79E5E840C149Q37664119-4313FD76-15AB-4BDF-A6EE-2989CBCB010CQ37940359-D382DA00-0613-478B-A2B6-EC079ABC4527Q38428314-CD3386F8-57F3-48E0-9F56-AC9720815966Q38464573-674566C2-BB66-4F6D-9667-3BFDF4637538Q38684782-C35EBBC4-E326-498F-964B-595CB6693FA5Q40063451-68DE2945-4429-4DC9-A252-DB0F8496898FQ40215776-29D66225-4AAA-4D42-BC07-0170FCBF1633Q42874764-B0B7FBC9-BFD5-40B5-A662-4E6CD80448EBQ43551689-82341947-7E2C-469E-AEE4-C797F8BDB62BQ44174971-B8B91E6A-9840-4711-A1A2-FD3965EA45DAQ44250177-74BB56DE-731A-46AF-8BEF-2C3CEED868CDQ44316812-DCCCBEAF-7EC4-404A-9778-B70640064029Q44490089-DB3F8C4A-7732-4EDC-A3CA-7EAD2C8A5702Q44842467-C3E35A95-6B3F-49CE-9C32-D4CC965FC23BQ45274151-EA0D53FF-45B1-49FA-A865-31D645A1ECDEQ45408706-55185A03-2DED-4322-9F6B-C475EAB6D211Q45962943-C61C8E84-BA1B-4B08-B057-DE27C437ECA4Q46448309-DB733522-A45D-45D9-A5C7-60B22E9234DBQ46472377-333C4654-5D8B-4CB5-90E0-0C3F113894E0Q46890975-2812D2AC-3722-4FBC-A12D-E9CB545BB634Q46914305-AC67BFED-3C4E-42F6-9AD7-2232084A65EFQ47838942-BDC5B6BE-5319-4F32-AC92-D03045322A78Q47927002-6B60313C-607A-4D0C-B7DF-52E860F92947Q47966710-43B586EA-3555-44D0-BEEB-D91FEFF73623Q48159444-FFAB677E-BDCA-4936-9942-4EE250290DAFQ48171244-BC8FDF87-478E-4DAF-8E97-3D2B349F9067Q48190683-942BF561-3A77-445C-B56E-4FD0A19A3013Q48197712-1050D7A3-4357-402A-BEAB-D348CC12BB69Q48200005-E2011FEA-C956-47DE-8FC7-5FCB540ABEE1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Patrick Santens
@ast
Patrick Santens
@en
Patrick Santens
@es
Patrick Santens
@nl
Patrick Santens
@sl
type
label
Patrick Santens
@ast
Patrick Santens
@en
Patrick Santens
@es
Patrick Santens
@nl
Patrick Santens
@sl
prefLabel
Patrick Santens
@ast
Patrick Santens
@en
Patrick Santens
@es
Patrick Santens
@nl
Patrick Santens
@sl
P106
P1153
7006128792
P21
P31
P496
0000-0002-8886-9776